- vanya
- 30 Dec, 2002
- New York City
Although the bleak environment of the broader market in 2002 extended to the IPO arena too, there still was good news for investors as new issues outperformed the market as a whole
- kalina
- 26 Dec, 2002
- New York City
Hopes of an imminent biotech-sector recovery were fanned following news that two vital drugs had gained panel recommendations, placing them on the threshold of regulatory approval.
- vanya
- 17 Dec, 2002
- New York City
Online banking failed to live up to its hype, but today, consumers have begun warming up to the idea of banking on the Web. Which players are set to gain from the renewed interest?
- kalina
- 16 Dec, 2002
- New York City
The growing number of cash-hungry biotechs is bound to incite a wave of deals leading to sector consolidation. Biotech leader Gilead Sciences has already benefited from such a deal
- iliana
- 10 Dec, 2002
- New York City
Luxury hotels Starwood and Orient-Express have suffered sorely due to the economic downturn. But, their strong brand presence and margins give them plenty of upside potential.
- kalina
- 04 Dec, 2002
- New York City
The upcoming ASH meeting has been attracting the attention of not only scientists but also investors. This interest may prove to be a boon for biotech stocks in the short run.
- vanya
- 03 Dec, 2002
- New York City
The Sept. 11 attacks and the market downturn have taken their toll on the insurance business, but investors may still find good opportunities in some property and casualty insurers
- kalina
- 26 Nov, 2002
- New York City
Despite the ongoing Federal investigation into the business practices of pharmacy benefit managers (PBMs), hurting sector stocks, their long-term potential remains quite promising.
- iliana
- 24 Nov, 2002
- New York City
Sears may need some help from its customers to achieve a major rebound, and a little more trust from investors to transform once again into a must-have stock.
- vanya
- 18 Nov, 2002
- New York City
Websense is among the few players in the Web filtering arena that claims to have an answer to a large looming corporate problem - the waste of time and money on the Net.
- kalina
- 13 Nov, 2002
- New York City
The market rally in October helped to fuel the recovery of both pharmaceutical and biotech sector stocks, raising hopes that they are on track to post a better performance in 2003.
- iliana
- 07 Nov, 2002
- New York City
Possessing strong fundamentals and accelerating earnings growth, the restaurant sector offers some appetizing stocks. Nevertheless, there is need for investors to be selective.
- vanya
- 05 Nov, 2002
- New York City
The VC market has long been expected to emerge from two consecutive years of decline. But, a look at the latest quarterly numbers reveals that it has still not reached the bottom.
- kalina
- 01 Nov, 2002
- New York City
President Bush's recent proposal to speed up introduction of generic drugs into the market and thus slash costs for consumers, has pushed generic drug stocks into the spotlight.
- iliana
- 25 Oct, 2002
- New York City
Though currently they seem overpriced, dollar-store stocks possess some of the solid fundamentals the market is looking for today. And, their prospects have never been brighter.